PEDIATRICS Vol. 38 No. 2 August 1966, pp. 307-309
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BIERMAN, C. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by BIERMAN, C. W.

Results of a Questionnaire Concerning the Use of Aminophylline in the Therapy of Childhood Asthma

C. WARREN BIERMAN M.D.1

1 Division of Allergy, Departments of Medicine and Pediatrics, University of Washington School of Medicine, Seattle, Washington 98105

Since 1937, when intravenous administration of theophylline-ethylenediamine (aminophylline) was shown to be effective in treating status asthmaticus, theophylline preparations have been employed extensively in the therapy of asthma. Reports of severe toxicity and deaths from aminophylline in children, have made the proper use of such drugs in childhood asthma a matter of concern to pediatricians. Accordingly, questionnaires about the use of aminophylline in asthmatic children were sent to 15 members of the Section on Allergy of the American Academy of Pediatrics, the majority of whom head Pediatric Allergy Fellowship Programs. The replies received from 14 are summarized here.